咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >A clinically relevant combinat... 收藏

A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice

作     者:Satyanarayana R Pondugula Julia M Salamat Kodye L Abbott Patrick C Flannery Mohammed Majrashi Mohammed Almaghrabi Manoj Govindarajulu Sindhu Ramesh Maninder Sandey Suneel K Onterue Chen-Che J Huang Yoshimi Iwaki Kristina Gill Natasha Narayanan Edwin McElroy Darshini Desai Rishi Nadar Timothy Moore Muralikrishnan Dhanasekaran Satyanarayana R Pondugula;Julia M Salamat;Kodye L Abbott;Patrick C Flannery;Mohammed Majrashi;Mohammed Almaghrabi;Manoj Govindarajulu;Sindhu Ramesh;Maninder Sandey;Suneel K Onteru;Chen-Che J Huang;Yoshimi Iwaki;Kristina Gill;Natasha Narayanan;Edwin McElroy;Darshini Desai;Rishi Nadar;Timothy Moore;Muralikrishnan Dhanasekaran

作者机构:Department of AnatomyPhysiology and PharmacologyCollege of Veterinary MedicineAuburn UniversityAuburnALUSA Department of PharmacologyFaculty of MedicineUniversity of JeddahJeddahSaudi Arabia Department of Drug Discovery and DevelopmentHarrison School of PharmacyAuburn UniversityAuburnALUSA Department of PathobiologyCollege of Veterinary MedicineAuburn UniversityAuburnALUSA Animal Biochemistry DivisionNational Dairy Research InstituteICAR-National Dairy Research InstituteKarnalHaryanaIndia Department of Clinical ScienceCollege of Veterinary MedicineAuburn UniversityAuburnALUSA 

出 版 物:《Liver Research》 (肝脏研究(英文))

年 卷 期:2021年第5卷第4期

页      面:239-242页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基  金:This project was supported by Animal Health and Disease Research Grant and Auburn University Research Initiative in Cancer Grant to S.R Pondugula This work was also supported by the USA National Institutes of Health(NIH)R00 HD082686 Grant to C.-C.J Huang 

主  题:Cyclophosphamide(CPS) Doxorubicin(DOX) Hepatotoxicity Liver injury Muscle injury 

摘      要:Background and aims:Chronic exposure to chemotherapeutics can lead to severe adverse events including hepatotoxicity.A combination chemotherapy regimen of doxorubicin(DOX)and cyclophos-phamide(CPS)is employed in treatment of several cancers such as leukemia,lymphoma,and breast *** is not well understood whether a combination therapy with DOX and CPS can induce *** therefore sought to determine whether co-administration of DOX and CPS at their clini-cally relevant doses and frequency results in ***:Male C57BL/6J mice received one intraperitoneal injection of saline or DOX-2 mg/kg and CPS-50 mg/kg once a week for 4 *** the treatment period,liver histology and various serum bio-markers of hepatotoxicity were ***:Co-treatment with DOX and CPS did not alter the serum levels of alanine aminotransferase(ALT),alkaline phosphatase(ALP),bilirubin,albumin,globulin,or total ***,co-administration of DOX and CPS did not result in a noticeable change in liver ***,it was notable that the concomitant treatment with DOX and CPS resulted in a significant increase in serum levels of aspartate aminotransferase(AST).Elevated serum AST levels were also associated with increased serum creatinine kinase(CK)levels,suggesting that the elevated serum AST levels are likely due to muscle injury following the co-administration of DOX and ***:Taken together,our results,for the first time,suggest that co-administration of DOX and CPS,at their clinically relevant doses and frequency does not induce a significant hepatotoxicity in the mice.

读者评论 与其他读者分享你的观点